IRVING, Texas, February 5, 2025 – McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected Lynne Doughtie and Dr. Julie Gerberding to join the board, effective February 3, 2025. Ms. Doughtie will serve on the Audit Committee and the Finance Committee, and Dr. Gerberding will serve on the Compliance Committee and the Compensation and Talent Committee.
“We are thrilled to welcome Ms. Doughtie and Dr. Gerberding to our board of directors,” said Donald Knauss, McKesson’s independent board chair. “Their exceptional leadership and deep expertise will bring valuable perspectives to McKesson and our purpose of Advancing Health Outcomes for All®. These appointments reflect our commitment to fostering strategic insights and oversight that drive shareholder value.”
Ms. Doughtie brings accounting and finance expertise as the former Chair and Chief Executive Officer of KPMG U.S. Ms. Doughtie spent over 30 years at KPMG, during which she gained depth of experience across various industries, including technology, healthcare, and financial services. She currently serves on the board of directors of The Boeing Company and Workday, Inc. Ms. Doughtie received her B.S. in accounting from Virginia Polytechnic Institute and State University (Virginia Tech)/Pamplin College of Business in 1985, as well as her certification as a public accountant.
Dr. Gerberding brings extensive executive experience in the healthcare industry and public policy as the Chief Executive Officer of the Foundation for the National Institutes of Health. Previously, she served as the Executive Vice President and Chief Patient Officer at Merck & Co., and she also served as the Director of the Centers for Disease Control and Prevention. Dr. Gerberding currently serves on the board of directors of Hillevax, Inc., a biopharmaceutical company focused on the development and commercialization of novel vaccines. She received her undergraduate and medical degrees from Case Western Reserve University and a Master of Public Health at the University of California, Berkeley.
With these appointments, the McKesson board increases to 13 members, 12 of whom are independent.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
Contact
Investors
Investors@McKesson.com
Media Relations
MediaRelations@McKesson.com